NASDAQ · GWRS

Global Water Resources, Inc.

$7.58 +$0.22 (+2.99%) 1D Market open

Key Metrics

$211.70M
Market cap
105.85×
P/E · TTM
$56.59M
Revenue · TTM
$2.00M
Net income
EPS · TTM $0.08
Dividend yield 4.0%
Free cash flow −$41.22M
Beta · 1Y 0.57
EBITDA · TTM $18.67M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • May 13
    From its Feb 13 high, the share price fell 28%.

    Peak close $9.19 on Feb 13; trough close $6.66 on May 13. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -28%
  • Mar 5
    The stock moved -13.9% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 5

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$211.70M
Enterprise value$343.59M
Shares outstanding28.8M
52-wk range$6.55 – $11.17
Avg volume · 20D39.2K
Net cash −$131.89M
Book value / share$3.45
IndustryWater Supply
ExchangeNASDAQ
About Global Water Resources, Inc.
IPO dateApr 28, 2016
Employees129

Global Water Resources Inc operates as a water resources management company that owns, operates, and manages water, wastewater, and recycled water utilities in strategically located communities, principally in metropolitan Phoenix and Tucson, Arizona. It operates within the State of Arizona.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E105.85
P/S3.74
P/FCF
EV/EBITDA18.40
EV/Sales6.07
Graham №$2.52

Profitability

Gross
Operating 4.8%
Net 3.5%
FCF -72.8%
ROE / ROIC 3.0% · 0.9%

Financial Health

Current ratio0.68
Quick ratio
Debt / equity1.59
Debt / EBITDA 7.16
Net cash −$131.89M
Working capital−$6.41M

Cash Flow · TTM

Operating CF $17.17M
Capex −$58.38M
Free cash flow −$41.22M
Buybacks
Dividends paid $8.55M
Shareholder yield 4.0%

Piotroski F-Score

4 / 9
Middling fundamentals · 4 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

$2.52 vs $7.35
Trades 2.9× above classic defensive value — priced for growth
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings